Full-Time

Commercial Analyst

Confirmed live in the last 24 hours

LGC Group

LGC Group

1,001-5,000 employees

Provides scientific tools for life sciences

No salary listed

Junior, Mid

Alexandria, MN, USA

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Power BI
Financial analysis
Tableau
Salesforce
Data Analysis
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a LGC Group referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Bachelor’s degree or equivalent experience in business, marketing or related field.
  • Proven track record in financial and sales data analysis in a relevant market sector with shown experience and skills.
  • Experience in reporting and visualization tools (e.g. Power BI, Tableau, Business Objects, Salesforce.com, etc.)
  • Good understanding of statistical methods and the ability to apply them to real-world data.
  • Experience in data mining, manipulation, and analysis in multiple database systems.
  • Excellent interpersonal skills that focus on transparency and simplicity, both written and oral with ability.
  • Work autonomously and able to balance multiple projects simultaneously; ability to effectively work on many priorities at one time, which change frequently.
Responsibilities
  • Proactively review and report on commercial performance across regions, territories, and accounts.
  • Content generation and support of routine monthly and quarterly reporting requirements and presentations.
  • Maintains master alignment of accounts and sales territories; updates and/or input of accurate information into ERP and Salesforce systems to ensure data integrity.
  • Conduct analysis for commercial business related to budgeting and forecasting on a regional and global scale.
  • Support Commercial Directors in regional data analysis requirements and opportunity identification.
  • Propose, develop and implement improvements to reporting tools through the identification of key leading and lagging indicators.
  • Recommends data requirement standards to ERP and Business Object teams.
  • Improve revenue opportunities. This will include price elasticity modeling, proposal pricing analysis, pro forma projections with key opportunities, and other similar duties.
  • Closely studies past sales data to determine trends and shares with sales leadership.
  • Run the daily product tracking report that will communicate demand, revenue recognition, product testing and commercial launch execution.
  • Produce critical metric updates for product launch and performance tracking.
Desired Qualifications
  • Leadership experience desired.
  • Industry experience (life sciences, biotech) or experience in a global organization preferred.
  • Leading sophisticated projects with multiple customers to successful completion.

LGC Group provides scientific tools and solutions that support advancements in healthcare and pharmaceuticals. Their products include oligo components, probes, primers, and recombinant viral materials, which are essential for detecting diseases and developing vaccines and therapies for various illnesses, including cancer and infectious diseases like COVID-19. LGC serves a wide range of clients, such as healthcare professionals and pharmaceutical companies, and generates revenue through the sale of these specialized tools and proficiency testing schemes that ensure food safety. What sets LGC apart from competitors is its strong focus on quality and innovation, which helps improve healthcare outcomes and contributes to a safer world.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1841

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for nucleic acid-based diagnostics boosts LGC's market potential.
  • AI integration in lab processes enhances LGC's efficiency in mass spectrometry and immunoassay.
  • Acquisitions like DiaMex and Virusys strengthen LGC's clinical diagnostics portfolio.

What critics are saying

  • Increased competition from emerging markets may impact LGC's market share.
  • Rapid technological advancements could render LGC's products obsolete without innovation.
  • Supply chain vulnerabilities could lead to production delays and increased costs.

What makes LGC Group unique

  • LGC Group offers a comprehensive range of high-quality scientific tools and solutions.
  • The company has a strong focus on nucleic acid chemistry and recombinant viral materials.
  • LGC's proficiency testing schemes enhance food safety and healthcare outcomes globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Remote Work Options

Company News

GBJPL
Apr 15th, 2025
Ensuring Precision in Analysis: Graham B Jackson Pty Ltd Supply of LGC Certified Reference Materials

Graham B Jackson Pty Ltd (GBJPL), an Australian leader in reference materials, partners with the globally renowned LGC Group to supply high-quality CRMs to laboratories across the country.

Health Technology Insights
Apr 4th, 2025
Laboratory Proficiency Testing Market to Reach $2.1 Billion by 2030

For example, LGC Group introduced a proficiency testing (PT) service in April 2020 that uses nucleic acid amplification testing to identify SARS-CoV-2 (COVID-19).

Investors in Healthcare
Jan 10th, 2025
UK: LGC appoints Joydeep Goswami as president and CEO

UK-based LGC, an international life sciences measurement and tools company, has appointed Joydeep Goswami as president and CEO, succeeding Euan O'Sullivan, who decided to step down from his role in early 2024 after fourteen years of service.

LGC Group
Dec 4th, 2024
LGC acquires DiaMex to drive innovation and choice for core laboratory customers: Acquisition complements LGC's serology and molecular quality control portfolio and enhances choice of products from a single supplier

LGC acquires DiaMex to drive innovation and choice for core laboratory customers: acquisition complements LGC's serology and molecular quality control portfolio and enhances choice of products from a single supplier.

LGC Group
Dec 4th, 2024
LGC acquires DiaMex to drive innovation and choice for core laboratory customers

London, UK – 4 December 2024 – LGC today announces an addition to its growing global clinical diagnostics and genomics portfolio, following the acquisition of DiaMex, a manufacturer of third-party serology and molecular quality controls used in clinical laboratories and blood banks across the world.